107 related articles for article (PubMed ID: 27004723)
1. Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.
Segnan N; Minozzi S; Armaroli P; Cinquini M; Bellisario C; González-Lorenzo M; Gianola S; Ponti A
Int J Cancer; 2016 Aug; 139(3):554-73. PubMed ID: 27004723
[TBL] [Abstract][Full Text] [Related]
2. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
4. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
5. Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project.
Kroenke CH; Michael YL; Poole EM; Kwan ML; Nechuta S; Leas E; Caan BJ; Pierce J; Shu XO; Zheng Y; Chen WY
Cancer; 2017 Apr; 123(7):1228-1237. PubMed ID: 27943274
[TBL] [Abstract][Full Text] [Related]
6. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
7. Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
Dudani S; Mazzarello S; Hilton J; Hutton B; Vandermeer L; Fernandes R; Ibrahim MF; Smith S; Majeed H; Al-Baimani K; Caudrelier JM; Shorr R; Clemons M
Clin Breast Cancer; 2016 Dec; 16(6):456-470. PubMed ID: 27553811
[TBL] [Abstract][Full Text] [Related]
8. Is DCIS Overrated?
Feinberg J; Wetstone R; Greenstein D; Borgen P
Cancer Treat Res; 2018; 173():53-72. PubMed ID: 29349758
[TBL] [Abstract][Full Text] [Related]
9. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
10. Is carcinoma in situ a precursor lesion of invasive breast cancer?
To T; Wall C; Baines CJ; Miller AB
Int J Cancer; 2014 Oct; 135(7):1646-52. PubMed ID: 24615647
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.
Mutter RW; Frost MH; Hoskin TL; Johnson JL; Hartmann LC; Boughey JC
Breast Cancer Res Treat; 2015 Aug; 153(1):183-90. PubMed ID: 26210521
[TBL] [Abstract][Full Text] [Related]
12. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer detection method among 20- to 49-year-old patients at a community based cancer center: 1990-2008.
Malmgren J; Atwood M; Kaplan H
Breast J; 2012; 18(3):257-60. PubMed ID: 22487162
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
15. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer in young women in Latin America: an unmet, growing burden.
Villarreal-Garza C; Aguila C; Magallanes-Hoyos MC; Mohar A; Bargalló E; Meneses A; Cazap E; Gomez H; López-Carrillo L; Chávarri-Guerra Y; Murillo R; Barrios C
Oncologist; 2013; 18 Suppl():26-34. PubMed ID: 24334479
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.
Thomas ET; Del Mar C; Glasziou P; Wright G; Barratt A; Bell KJL
BMC Cancer; 2017 Dec; 17(1):808. PubMed ID: 29197354
[TBL] [Abstract][Full Text] [Related]
19. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
Sopik V; Iqbal J; Sun P; Narod SA
Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
[TBL] [Abstract][Full Text] [Related]
20. The natural history of invasive breast cancers detected by screening mammography.
Zahl PH; Maehlen J; Welch HG
Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
